Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LBC 45 for moderate to severe seborrheic dermatitis of the scalp
2010-022861-93Phase 2Active
- Sponsor
- Labcatal
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of lithium gluconate in seborrheic dermatitis (SD) (3 arms), sponsored by Labcatal. Primary endpoint: Sum of erythema and scaling scores at Day 56. Started Oct 2010; status: active.
02
Drugs
lithium gluconate
03
Conditions
seborrheic dermatitis (SD)
Beyond the preview
Go deeper on 2010-022861-93.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022861-93.